EdgarLookup

Neuphoria Therapeutics Inc. — All Filings

408 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 12G3-2B 15-12G 20-F 20-F/A 3 4 4/A 424B3 424B4 424B5 6-K 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DEFC14A DFAN14A DFRN14A DRS DRS/A DRSLTR EFFECT F-1 F-1/A F-1MEF F-3 F-6 NT 10-Q POS AM PRE 14A PREC14A S-3 S-3/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SUPPL UPLOAD
Form Description Accession Number Filed Period
10-Q 10-Q 0001193125-26-054509 Feb 17, 2026 Dec 31, 2025
SCHEDULE 13G/A 0001957912-26-000007 Feb 6, 2026
4 0001213900-26-006173 Jan 21, 2026 Jan 20, 2026
4 0001213900-26-006171 Jan 21, 2026 Jan 20, 2026
4 0001213900-26-006172 Jan 21, 2026 Jan 20, 2026
4 0001213900-26-006170 Jan 21, 2026 Jan 20, 2026
8-K CURRENT REPORT 0001213900-26-002245 Jan 8, 2026 Dec 31, 2025
SCHEDULE 13D/A 0000905148-25-004490 Dec 29, 2025
8-K CURRENT REPORT 0001213900-25-123289 Dec 18, 2025
8-K CURRENT REPORT 0001213900-25-122777 Dec 17, 2025 Dec 12, 2025
DFAN14A DFAN14A 0001193125-25-311436 Dec 8, 2025
DFAN14A DFAN14A 0001193125-25-311358 Dec 8, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-119241 Dec 8, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-118291 Dec 4, 2025
DFAN14A DFAN14A 0001193125-25-305885 Dec 3, 2025
DFAN14A DFAN14A 0001193125-25-305468 Dec 2, 2025
SCHEDULE 13D/A 0000905148-25-004208 Dec 2, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-116694 Dec 1, 2025
SCHEDULE 13D/A 0000905148-25-004191 Nov 28, 2025
DFAN14A DFAN14A 0001193125-25-300651 Nov 26, 2025
DFRN14A DFRN14A 0001193125-25-297599 Nov 25, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-114764 Nov 25, 2025
DEFA14A DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-114148 Nov 24, 2025
DEFC14A DEFC14A 0001140361-25-043032 Nov 24, 2025
DEFC14A DEFC14A 0001193125-25-291924 Nov 24, 2025
SCHEDULE 13D/A 0000905148-25-004110 Nov 18, 2025
PREC14A PREC14A 0001193125-25-283303 Nov 14, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-110865 Nov 14, 2025
10-Q 10-Q 0001193125-25-281579 Nov 14, 2025 Sep 30, 2025
DEFA14A SOLICITING MATERIAL UNDER 240. RULE 14A-12 0001213900-25-108515 Nov 12, 2025
PREC14A PREC14A 0001140361-25-041500 Nov 12, 2025
SCHEDULE 13D/A 0000905148-25-003859 Nov 10, 2025
SCHEDULE 13G 0001104659-25-106789 Nov 5, 2025
SCHEDULE 13G 0001957912-25-000007 Oct 31, 2025
SCHEDULE 13G 0001723643-25-000015 Oct 31, 2025
DEFA14A DEFA14A 0001140361-25-039749 Oct 30, 2025
DEF 14A DEF 14A 0001140361-25-039748 Oct 30, 2025 Dec 9, 2025
8-K CURRENT REPORT 0001213900-25-102607 Oct 27, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-102387 Oct 27, 2025
SCHEDULE 13D 0000902664-25-004537 Oct 23, 2025
4 0000902664-25-004536 Oct 23, 2025 Oct 21, 2025
3 0000902664-25-004535 Oct 23, 2025 Oct 21, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-100387 Oct 20, 2025
8-K CURRENT REPORT 0001213900-25-100371 Oct 20, 2025
10-K 10-K 0001193125-25-223338 Sep 29, 2025 Jun 30, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-090330 Sep 23, 2025
8-K CURRENT REPORT 0001213900-25-087950 Sep 16, 2025 Sep 10, 2025
4 0001213900-25-082904 Sep 2, 2025 Aug 27, 2025
424B5 PROSPECTUS SUPPLEMENT 0001213900-25-068691 Jul 29, 2025
8-K CURRENT REPORT 0001213900-25-065723 Jul 18, 2025